{"id":925621,"date":"2026-01-08T18:18:13","date_gmt":"2026-01-08T23:18:13","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\/"},"modified":"2026-01-08T18:18:13","modified_gmt":"2026-01-08T23:18:13","slug":"biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\/","title":{"rendered":"BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT \/ 2:15 pm ET, in San Francisco, CA"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n SAN RAFAEL, Calif.<\/span>, Jan. 8, 2026<\/span> \/PRNewswire\/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will present at the 44th Annual J.P. Morgan Conference on Monday, January 12, 2026, at 11:15 am PT \/ 2:15 pm ET, in San Francisco, California. The Company plans to announce certain preliminary financial results for the year ended December 31, 2025 at such event. \u00a0<\/p>\n

\n

\n
\n \"BioMarin
\n <\/a>\n <\/p>\n<\/p><\/div>\n

An audio webcast of the presentation will be available live. You can access the webcast at: https:\/\/investors.biomarin.com\/<\/a>. An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.\u00a0<\/p>\n

\n About BioMarin
<\/b>BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the\u202fSan Rafael, California-based company has a proven track record of innovation, with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. To learn more, please visit\u00a0www.biomarin.com<\/a>. \u00a0\u202f<\/p>\n

\n\n\n\n\n\n\n
\n

\n Contacts:<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Investors<\/span>\n <\/p>\n<\/td>\n

\n

\n Media<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Traci McCarty<\/i>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Marni Kottle<\/i>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n BioMarin Pharmaceutical Inc.\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/i>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n BioMarin Pharmaceutical Inc.<\/i>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n (415) 455-7558 <\/i>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n (650) 374-2803<\/i>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/biomarin-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt–215-pm-et-in-san-francisco-ca-302656804.html<\/a><\/p>\n

SOURCE BioMarin Pharmaceutical Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire SAN RAFAEL, Calif., Jan. 8, 2026 \/PRNewswire\/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will present at the 44th Annual J.P. Morgan Conference on Monday, January 12, 2026, at 11:15 am PT \/ 2:15 pm ET, in San Francisco, California. The Company plans to announce certain preliminary financial results for the year ended December 31, 2025 at such event. \u00a0 An audio webcast of the presentation will be available live. You can access the webcast at: https:\/\/investors.biomarin.com\/. An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.\u00a0 About BioMarinBioMarin is a leading, global rare disease biotechnology … <\/p>\n

Continue reading “BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT \/ 2:15 pm ET, in San Francisco, CA”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-925621","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT \/ 2:15 pm ET, in San Francisco, CA - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT \/ 2:15 pm ET, in San Francisco, CA - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SAN RAFAEL, Calif., Jan. 8, 2026 \/PRNewswire\/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will present at the 44th Annual J.P. Morgan Conference on Monday, January 12, 2026, at 11:15 am PT \/ 2:15 pm ET, in San Francisco, California. The Company plans to announce certain preliminary financial results for the year ended December 31, 2025 at such event. \u00a0 An audio webcast of the presentation will be available live. You can access the webcast at: https:\/\/investors.biomarin.com\/. An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.\u00a0 About BioMarinBioMarin is a leading, global rare disease biotechnology … Continue reading "BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT \/ 2:15 pm ET, in San Francisco, CA"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-08T23:18:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/534018\/BioMarin_Pharmaceutical_Inc_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT \\\/ 2:15 pm ET, in San Francisco, CA\",\"datePublished\":\"2026-01-08T23:18:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\\\/\"},\"wordCount\":250,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/534018\\\/BioMarin_Pharmaceutical_Inc_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\\\/\",\"name\":\"BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT \\\/ 2:15 pm ET, in San Francisco, CA - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/534018\\\/BioMarin_Pharmaceutical_Inc_Logo.jpg\",\"datePublished\":\"2026-01-08T23:18:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/534018\\\/BioMarin_Pharmaceutical_Inc_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/534018\\\/BioMarin_Pharmaceutical_Inc_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT \\\/ 2:15 pm ET, in San Francisco, CA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT \/ 2:15 pm ET, in San Francisco, CA - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\/","og_locale":"en_US","og_type":"article","og_title":"BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT \/ 2:15 pm ET, in San Francisco, CA - Market Newsdesk","og_description":"PR Newswire SAN RAFAEL, Calif., Jan. 8, 2026 \/PRNewswire\/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will present at the 44th Annual J.P. Morgan Conference on Monday, January 12, 2026, at 11:15 am PT \/ 2:15 pm ET, in San Francisco, California. The Company plans to announce certain preliminary financial results for the year ended December 31, 2025 at such event. \u00a0 An audio webcast of the presentation will be available live. You can access the webcast at: https:\/\/investors.biomarin.com\/. An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.\u00a0 About BioMarinBioMarin is a leading, global rare disease biotechnology … Continue reading \"BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT \/ 2:15 pm ET, in San Francisco, CA\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\/","og_site_name":"Market Newsdesk","article_published_time":"2026-01-08T23:18:13+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/534018\/BioMarin_Pharmaceutical_Inc_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT \/ 2:15 pm ET, in San Francisco, CA","datePublished":"2026-01-08T23:18:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\/"},"wordCount":250,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/534018\/BioMarin_Pharmaceutical_Inc_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\/","name":"BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT \/ 2:15 pm ET, in San Francisco, CA - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/534018\/BioMarin_Pharmaceutical_Inc_Logo.jpg","datePublished":"2026-01-08T23:18:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/534018\/BioMarin_Pharmaceutical_Inc_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/534018\/BioMarin_Pharmaceutical_Inc_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomarin-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-monday-january-12-at-1115-am-pt-215-pm-et-in-san-francisco-ca\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT \/ 2:15 pm ET, in San Francisco, CA"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/925621","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=925621"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/925621\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=925621"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=925621"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=925621"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}